tysabri
biogen netherlands b.v. - natalizumab - multipla skleroza - selektivni imunosupresivi - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
tyruko
sandoz gmbh - natalizumab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresivi - tyruko is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis (rrms) for the following patient groups: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 i 5. 1), or, patients with rapidly evolving severe rrms defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain magnetic resonance imaging (mri) or a significant increase in t2 lesion load as compared to a previous recent mri.
stocrin
merck sharp & dohme b.v. - efavirenz - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - stocrin je indiciran u antivirusnom kombiniranom tretmanu odraslih, adolescenata i djece starijih od tri godine starijih od ljudske imunodeficijencije-1 (hiv-1). Стокрин nisu bili pravilno istražena u bolesnika s uznapredovalom faze infekcije hiv-om, a upravo je u bolesnika s razinom cd4 < 50 ćelija/mm3, ili nakon neuspjeha протеаза-inhibitora (pi)-sadrže sheme. iako je cross-otpornost эфавиренза sa ip nije bio registriran, trenutno nema dovoljno podataka o efikasnosti kasniju upotrebu pi na temelju kombinirane terapije neučinkovitosti sheme sadrže Стокрин.
orvagil 500 mg/1 vagitorija vagitorija
galenika d.o.o. - metronidazol - vagitorija - 500 mg/1 vagitorija - 1 vagitorija sadrži: 500 mg metronidazola
colpocint 500 mg/100 ml rastvor za infuziju
krajinagroup d.o.o. banja luka - metronidazol - rastvor za infuziju - 500 mg/100 ml - 100 ml rastvora za infuziju sadrži: 500 mg metronidazol
orvagil 500 mg/1 vagitorija vagitorija
galenika d.o.o. - metronidazol - vagitorija - 500 mg/1 vagitorija - 1 vagitorija sadrži: 500 mg metronidazola
cerebryl 800 mg/1 tableta filmom obložena tableta
viennapharm d.o.o. - пирацетам - filmom obložena tableta - 800 mg/1 tableta - 1 filmom obložena tableta sadrži: 800 mg piracetama
cerebryl 1200 mg/1 tableta filmom obložena tableta
viennapharm d.o.o. - пирацетам - filmom obložena tableta - 1200 mg/1 tableta - 1 filmom obložena tableta sadrži: 1200 mg piracetama
cerebryl 1200 mg/1 tableta filmom obložena tableta
viennapharm d.o.o. - пирацетам - filmom obložena tableta - 1200 mg/1 tableta - 1 filmom obložena tableta sadrži: 1200 mg piracetama
cerebryl 800 mg/1 tableta filmom obložena tableta
viennapharm d.o.o. - пирацетам - filmom obložena tableta - 800 mg/1 tableta - 1 filmom obložena tableta sadrži: 800 mg piracetama